TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW OF GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET 23
1.4 CURRENCY AND PRICING 25
1.5 LIMITATIONS 25
1.6 MARKETS COVERED 25
2 MARKET SEGMENTATION 28
2.1 MARKETS COVERED 28
2.2 GEOGRAPHICAL SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 CURRENCY AND PRICING 30
2.5 DBMR TRIPOD DATA VALIDATION MODEL 31
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7 DBMR MARKET POSITION GRID 35
2.8 DBMR MARKET CHALLENGE MATRIX 36
2.9 DBMR VENDOR SHARE ANALYSIS 37
2.10 MULTIVARIATE MODELING 37
2.11 PRODUCTS LIFELINE CURVE 38
2.12 SECONDARY SOURCES 39
2.13 ASSUMPTIONS 39
3 MARKET OVERVIEW 40
3.1 DRIVERS 42
3.1.1 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS) 42
3.1.2 INCREASING HEALTHCARE EXPENDITURE 42
3.1.3 GOVERNMENT POLICIES FOR PREVENTING HEALTH-ACQUIRED INFECTIONS (HAIS) 43
3.2 RESTRAINTS 44
3.2.1 HIGH COST OF SOFTWARE 44
3.2.2 DEARTH OF SKILLED IT PROFESSIONALS IN THE HEALTHCARE INDUSTRY 44
3.3 OPPORTUNITIES 45
3.3.1 CLOUD-BASED SOFTWARE OFFERS SIGNIFICANT GROWTH OPPORTUNITIES 45
3.3.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS ASIA-PACIFIC AND LATIN AMERICA 45
3.4 CHALLENGE 46
3.4.1 DATA SECURITY RISK 46
4 EXECUTIVE SUMMARY 47
5 PREMIUM INSIGHTS 50
6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 52
6.1 OVERVIEW 53
6.2 SOFTWARE 54
6.2.1 WEB BASED 54
6.2.2 ON-PREMISE 54
6.3 SERVICES 55
6.3.1 TRAINING & CONSULTING SERVICES 55
6.3.2 IMPLEMENTATION SERVICES 55
6.3.3 PRODUCT SUPPORT & MAINTENANCE SERVICES 56
7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE 57
7.1 OVERVIEW 58
7.2 SURGICAL SITE INFECTIONS (SSI) 59
7.3 URINARY TRACT INFECTIONS (UTI) 60
7.4 BLOOD STREAM INFECTIONS (BSI) 60
7.5 CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) 61
7.6 CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI) 61
7.7 OTHERS 62
8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER 63
8.1 OVERVIEW 64
8.2 HOSPITALS 65
8.2.1 LARGE HOSPITALS 66
8.2.2 MEDIUM-SIZED HOSPITALS 66
8.2.3 SMALL HOSPITALS 66
8.3 CLINICS 66
8.4 AMBULATORY SURGICAL CENTERS 67
8.5 LONG TERM CARE FACILITIES 67
8.5.1 NURSING HOMES 68
8.5.2 HOMECARE AGENCIES & SERVICES 68
8.5.3 ASSISTED LIVING FACILITIES 68
8.6 ACADEMIC INSTITUTES 68
8.7 OTHERS 69
9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY GEOGRAPHY 70
9.1 OVERVIEW 71
9.2 NORTH AMERICA 76
9.2.1 U.S. 82
9.2.2 CANADA 85
9.2.3 MEXICO 88
9.3 EUROPE 91
9.3.1 GERMANY 97
9.3.2 FRANCE 100
9.3.3 U.K. 103
9.3.4 ITALY 106
9.3.5 SPAIN 109
9.3.6 NETHERLANDS 112
9.3.7 SWITZERLAND 115
9.3.8 BELGIUM 118
9.3.9 RUSSIA 121
9.3.10 TURKEY 124
9.3.11 REST OF EUROPE 127
9.4 ASIA-PACIFIC 128
9.4.1 CHINA 134
9.4.2 JAPAN 137
9.4.3 SOUTH KOREA 140
9.4.4 INDIA 143
9.4.5 AUSTRALIA 146
9.4.6 SINGAPORE 149
9.4.7 THAILAND 152
9.4.8 MALAYSIA 155
9.4.9 INDONESIA 157
9.4.10 PHILIPPINES 160
9.4.11 REST OF ASIA-PACIFIC 163
9.5 SOUTH AMERICA 164
9.5.1 BRAZIL 170
9.5.2 REST OF SOUTH AMERICA 173
9.6 MIDDLE EAST & AFRICA 174
9.6.1 SOUTH AFRICA 180
9.6.2 REST OF MIDDLE EAST & AFRICA 183
10 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, COMPANY LANDSCAPE 184
10.1 COMPANY SHARE ANALYSIS: GLOBAL 184
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 185
10.3 COMPANY SHARE ANALYSIS: EUROPE 186
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 187
11 SWOT ANALYSIS 188
11.1 DATA BRIDGE MARKET RESEARCH ANALYSIS 191
12 COMPANY PROFILES 192
12.1 WOLTERS KLUWER 192
12.1.1 COMPANY SNAPSHOT 192
12.1.2 REVENUE ANALYSIS 192
12.1.3 COMPANY SHARE ANALYSIS 193
12.1.4 PRODUCT PORTFOLIO 193
12.1.5 RECENT DEVELOPMENTS 193
12.2 BD 194
12.2.1 COMPANY SNAPSHOT 194
12.2.2 REVENUE ANALYSIS 194
12.2.3 COMPANY SHARE ANALYSIS 195
12.2.4 PRODUCT PORTFOLIO 195
12.2.5 RECENT DEVELOPMENT 196
12.3 ILLUMINA, INC. 197
12.3.1 COMPANY SNAPSHOT 197
12.3.2 REVENUE ANALYSIS 197
12.3.3 COMPANY SHARE ANALYSIS 198
12.3.4 PRODUCT PORTFOLIO 198
12.3.5 RECENT DEVELOPMENTS 198
12.4 CERNER CORPORATION 199
12.4.1 COMPANY SNAPSHOT 199
12.4.2 REVENUE ANALYSIS 199
12.4.3 COMPANY SHARE ANALYSIS 200
12.4.4 PRODUCT PORTFOLIO 200
12.4.5 RECENT DEVELOPMENTS 200
12.5 BAXTER 201
12.5.1 COMPANY SNAPSHOT 201
12.5.2 REVENUE ANALYSIS 201
12.5.3 COMPANY SHARE ANALYSIS 202
12.5.4 PRODUCT PORTFOLIO 202
12.5.5 RECENT DEVELOPMENTS 202
12.6 GOJO INDUSTRIES, INC. 203
12.6.1 COMPANY SNAPSHOT 203
12.6.2 PRODUCT PORTFOLIO 203
12.6.3 RECENT DEVELOPMENT 203
12.7 IBM CORPORATION 204
12.7.1 COMPANY SNAPSHOT 204
12.7.2 REVENUE ANALYSIS 204
12.7.3 PRODUCT PORTFOLIO 205
12.7.4 RECENT DEVELOPMENT 205
12.8 RL SOLUTIONS 206
12.8.1 COMPANY SNAPSHOT 206
12.8.2 PRODUCT PORTFOLIO 206
12.8.3 RECENT DEVELOPMENT 206
12.9 S. C. JOHNSON & SON, INC. 207
12.9.1 COMPANY SNAPSHOT 207
12.9.2 PRODUCT PORTFOLIO 207
12.9.3 RECENT DEVELOPMENT 207
12.10 VIGILANZ CORPORATION 208
12.10.1 COMPANY SNAPSHOT 208
12.10.2 PRODUCT PORTFOLIO 208
12.10.3 RECENT DEVELOPMENT 208
13 CONCLUSION 209
14 QUESTIONNAIRE 210
15 RELATED REPORTS 213